| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Daniel Gordon Kirby is Chief Commercial Officer at IOVA. Daniel Gordon Kirby's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.4M at current prices.
Net of sales, the IOVA filings show accumulation of 30,000 shares.
Daniel Gordon Kirby has 7 Form 4 filings on record from February 2025 to August 2026, all as Chief Commercial Officer at Iovance Biotherapeutics (IOVA), 2025–2026.
The 13 reported transactions were 4 option exercises, 4 tax withholdings, 4 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $55K and no sales.
The only open-market purchase was 30,000 shares of IOVA at an average $1.84 on June 5, 2025, about $55K. Twelve months later IOVA was up 135%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | IOVA Iovance Biotherapeutics, Inc. | Chief Commercial Officer | Buy | 30,000 | $1.84 | $55,200.00 | New | +22.8% | +135.0% |